Jivora Parvovirus B19 IgG-/IgM-antibodies™
Understanding your immune status is an essential part of proactive health for you and your family. Jivora Parvovirus B19 IgG-/IgM-antibodies™ is a professional laboratory screening designed to detect the immune system's response to Parvovirus B19—a common virus that can leave lasting immunological markers.
What is Parvovirus B19?
Often referred to as "Fifth Disease," Parvovirus B19 is a common virus that triggers a natural immune response. Once the body encounters the virus, it produces specific "defense proteins" (antibodies) that provide a high-resolution record of your exposure and immunity status.
Why Choose This Screening?
-
Dual-Antibody Mapping: This analysis simultaneously identifies IgM (recent response) and IgG (long-term memory) antibodies to provide a detailed view of your immune status.
-
Standardized Methodology: We utilize the ELISA technique, a widely recognized laboratory process for identifying the body's specific immune response to viral exposure.
-
Proactive Awareness: For those investigating lingering immune triggers or establishing a wellness baseline, this screening offers essential data to share with a healthcare professional.
Who It’s For:
-
Wellness Investigators: Individuals seeking to establish an immunological baseline following a period of joint discomfort or systemic fatigue.
-
Family Planning Proactives: Those interested in understanding their immunological history regarding common childhood viruses.
-
Functional Medicine Patients: Individuals mapping their immunological history to support a comprehensive wellness profile.
About Your Jivora Parvovirus B19 IgG-/IgM-antibodies™
Convenient Access to Wellness Insights
You can order your testing kit directly through Jivora Health, an authorized ArminLabs partner. Our streamlined online process respects your privacy and security, allowing you to take a proactive role in monitoring your immune health without the need for a prior office visit.
Simple, Needle-Free Collection at Home
Each kit features the FDA-cleared Tasso+ device, designed for easy and virtually painless blood collection from the upper arm. This innovative technology allows you to collect a high-quality sample without traditional needles. If you prefer, a standard clinical blood draw option is also available. Both methods are validated for sample stability and laboratory accuracy.
Informational Results for Better Conversations
Your report provides a detailed look at how your immune system reacts to specific tick-borne antigens. These findings are educational in nature and intended to help you have more informed discussions with your healthcare provider. Please note that these results are not a medical diagnosis and should not be used as a standalone basis for a treatment plan.
Medications and Testing
While most common medications do not impact the results, certain intensive therapies - such as strong immunosuppressants, chemotherapy, or interferon-gamma therapy - may affect your immune system’s natural reactivity. We recommend consulting your clinician before sample collection if you are currently undergoing these treatments.
Fast, Secure, and Supported
Once your sample is received by the laboratory, your secure digital report is typically available within 7 to 10 business days. To help you navigate your findings, Jivora Health provides access to a complimentary educational review to explain the data markers in your report.
Comprehensive Immune Screening
Traditional screenings often focus on a single strain of Borrelia. The ArminLabs approach provides a broader perspective by screening for reactivity to Borrelia burgdorferi, Borrelia afzelii, and Borrelia garinii. By including persistent-form (round-body) antigens, this test offers a more comprehensive view of your immune profile, reducing the limitations found in narrower testing methods.
Understanding Your Immune Markers
-
IgM Reactivity: Typically associated with a more recent or active immune response.
-
IgG Reactivity: Generally indicates an immune memory or long-term reactivity. ArminLabs calibrates these markers to provide you and your healthcare professional with a clear map of your immune system’s history and current status.
The Science of Antigen Diversity
Borrelia bacteria are known for their ability to shift forms, including "round-body" or pleomorphic states. Because these different forms can trigger different immune responses, our testing includes specific antigens for both active and persistent forms. This multi-antigen approach ensures a more thorough assessment of immune reactivity that standard screenings might overlook.
Regulatory Status: The Tasso+ collection device is FDA-cleared. The laboratory tests provided by ArminLabs are Laboratory Developed Tests (LDTs). These tests have not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary for LDTs when performed by a CLIA-certified laboratory.
Educational Use: These results are for informational purposes only. They are not intended to diagnose, treat, cure, or prevent any disease. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
*This test was developed and its performance characteristics determined by ArminLabs. It has not been cleared or approved by the U.S. Food and Drug Administration. This test is intended for informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
Technical Information ▼
▶ key fact
▶ material
▶ further information on the test
▶ further information on the pathogen
Transmission: Droplet infection. Lifelong immunity follows infection. Incubation period: approximately 1 week. Infectivity: 1 week before to 1 week after onset of illness.
Symptoms: Initially flu-like symptoms. 15–17 days after infection, fifth disease (Sticker's disease) appears: butterfly-shaped redness and swelling of the cheeks, spreading to the extensor surfaces of the arms, legs, and buttocks. Mucous membranes, palms, and soles are rarely affected. Joint inflammation (arthritis) may occur, particularly in finger, foot, and knee joints.
Mostly affects children aged 4–10, predominantly from June to November. Infection during pregnancy may result in spontaneous abortion, intrauterine death, hydrops fetalis, or growth retardation.
Important:These test results are for informational and educational purposes only. They provide immune response markers and are not intended to diagnose, treat, cure, or prevent any disease. This test should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making any health-related decisions based on test results.